Stenting for superficial femoral artery atherosclerotic occlusion: Long-term follow-up results

Heart and Vessels

Volumn 23, Issue 4, 2008, Pages 264-270

  Sasaki, Yoshio ^a   Hwang, Myung Woo ^b   Shirasawa, Kuniyuki ^b   Takeda, Shinichi ^b   Ayukawa, Hiroyuki ^b   Inenaga Kitaura, Katsura ^b   Takeoka, Rei ^b   Kitaura, Yasushi ^a   Kawai, Chuichi ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Ijinkai Takeda General Hospital   (Japan)

Author keywords

Occlusion; Patency; Percutaneous transluminal angioplasty; Stent; Superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PROTAMINE; TICLOPIDINE;

ABOVE KNEE AMPUTATION; ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FATALITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; LONG TERM CARE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN ULCER; STENT; SUPERFICIAL FEMORAL ARTERY; THREE DIMENSIONAL IMAGING; TREATMENT FAILURE; TREATMENT REFUSAL; TREATMENT RESPONSE; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RADIOGRAPHY, INTERVENTIONAL; STENTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 48549097577     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1043-z     Document Type: Article

References (16)

1. Isner JM, Rosenfield K (1993) Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization. Circulation 88:1534-1557
2. Pentecost MJ, Criqui MH, Dorros G, Goldstone J, Johnston KW, Martin EC, Ring EJ, Spies JB (1994) Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. Circulation 89:511-531
3. Laird JR (2006) Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 13:II30-II40
4. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, Lee DE, Waldman DL, Green RM (2005) Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41:269-278
5. Maca T, Schillinger M, Hamwi A, Mlekusch W, Sabeti S, Wagner O, Minar E. (2005) Insulin C-peptide and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients. J Vasc Interv Radiol 16(1):31-35
6. Maca T, Ahmadi R, Derfler K, Horl WH, Koppensteiner R, Minar E, Schneider B, Stumpflen A, Ehringer H (1996) Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? Atherosclerosis 127:27-34
7. Laird JR (2006) Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the super-ficial femoral and popliteal arteries. J Endovasc Ther 13:II30-II40
8. Myers SI, Myers DJ, Ahmend A, Ramakrishnan V (2006) Preliminary results of subintimal angioplasty for limb salvage in lower extremities with severe chronic ischemia and limb-threatening ischemia. J Vasc Surg 44:1239-1246
9. Wilson S, Gelfand D, Jimenez J, Gordon I (2006) Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease. Vascular 14:81-87
10. Lin J, Chen B, Wang JH. Zenq MS, Wanq YX (2006) Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels 21:395-398
11. Gordon IL, Conroy RM, Arefi M, Tobis JM, Stemmer EA, Wilson SE (2001) Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 136:221-228
12. Criado E, Burnham SJ, Tinsley EA Jr, Johnson G Jr, Keagy BA (1993) Femorofemoral bypass graft: Analysis of patency and factors influencing long-term outcome. J Vasc Surg 18:495-504; discussion 504-505
13. Ho GH, Moll FL, Tutein Nolthenius RP, van den Berg JC, Overtoom TT (2000) Endovascular femoropopliteal bypass combined with remote endarterectomy in SFA occlusive disease: Initial experience. Eur J Vasc Endovasc Surg 19:27-34
14. Aune S, Laxdal E (2000) Above-knee prosthetic femoropopliteal bypass for intermittent claudication. Results of the initial and secondary procedures. Eur J Vasc Endovasc Surg 19:476-480
15. Koch G, Gutschi S, Pascher O, Fruhwirth H, Glanzer H (1997) Analysis of 274 Omniflow Vascular Prostheses implanted over an eight-year period. Aust N Z J Surg 67:637-639
16. Rosenthal D, Arous EJ, Friedman SG, Ingegno MD, Johnson BL, Kraiss LW, Martin JD, Moritz MW, Piano G, Rigdon EE, Self SB, Pallos LL (2000) Endovascular-assisted versus conventional in situ saphenous vein bypass grafting: Cumulative patency, limb salvage, and cost results in a 39-month multicenter study. J Vasc Surg 31(1 Pt 1):60-68